Belgium vs Spain: Proportion of isolates with decreased susceptibility or resistance
Belgium
2.9
in 2018
Spain
4.8
in 2018
Belgium rank
7th
Spain rank
5th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Spain
How they compare
Spain currently reports 4.8 against 2.9 in Belgium, a difference of 1.9.
That makes Spain's figure about 1.7 times Belgium's.
The two have swapped places 3 times across 10 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 7th and Spain ranks 5th of 27 countries.
Across the 2 decades both report, Belgium averaged higher in 1 and Spain in 1.
Head to head by decade
| Decade | Belgium | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.36 | 0 | 6.36 | Belgium |
| 2010s | 5.34 | 8.39 | 3.05 | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Spain?
- Spain, at 4.8 against 2.9 in Belgium as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Spain?
- 1.9, with Spain ahead.
- How many years of comparable data are there for Belgium and Spain?
- 10 years are reported by both, from 2009 to 2018.
- How do Belgium and Spain rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 7th and Spain ranks 5th of 27 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.